Id http://purl.obolibrary.org/obo/NCIT_C2235
http://purl.obolibrary.org/obo/NCIT_C2235
Preferred Name

PR1 Leukemia Peptide Vaccine

Definitions
A cancer vaccine containing PR1, a 9 amino-acid human leukocyte antigen (HLA)-A2 restricted peptide derived from proteinase 3, with potential immunotherapeutic activity. Vaccination with PR1 leukemia peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing proteinase 3, resulting in tumor cell lysis. Often overexpressed in leukemic cells, proteinase 3 is a serine proteinase that activates progelatinase A and is involved in angiogenesis and metastasis.
Type http://www.w3.org/2002/07/owl#Class
Delete Subject Author Type Created
No notes to display